IRADIMED CORPORATION (IRMD:NASDAQ) closed at $86.31 on November 6, 2026, up 0.90% on the day. The stock trades 20.0% below its 52-week high of $107.90 and 13.0% above its 52-week low of $76.35. Over the past year, it gained 2.3%. IRADIMED CORPORATION is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since November 6, 2025, IRMD closed higher on 130 days (52%). Its best day was February 10, 2026 (+9.57%) and its worst was October 30, 2026 (-10.57%). The stock moved 10% or more in a single session 1 time.
Iradimed Corporation develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible products, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets under the MRidium name; and MRI compatible patient vital signs monitoring system under the IRadimed name. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories; iMagox MRI pulse oximeter; and iMagox MRI oximeter remote and display products. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its MRI compatible products through direct sales force and independent distributors. Iradimed Corporation was incorporated in 1992 and is headquartered in Winter Springs, Florida.
Find more stocks like IRMD with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.